Antongiulio Faggiano

Pubblicazioni

Titolo Pubblicato in Anno
Canine insulinoma as a model for human malignant insulinoma research: Novel perspectives for translational clinical studies TRANSLATIONAL ONCOLOGY 2022
The Strange Case of a Pancreatic Neuroendocrine Carcinoma with Low Proliferation Index and Atypical Clinical Behavior PANCREAS 2022
Prognostic significance of laterality in lung neuroendocrine tumors ENDOCRINE 2022
Effects of diet and antihyperglycemic drugs on erectile dysfunction. A systematic review ANDROLOGY 2022
Female infertility in the era of obesity: The clash of two pandemics or inevitable consequence? CLINICAL ENDOCRINOLOGY 2022
Effect of Neuroendocrine Neoplasm Treatment on Human Reproductive Health and Sexual Function JOURNAL OF CLINICAL MEDICINE 2022
Immunotherapy of Neuroendocrine Neoplasms: Any Role for the Chimeric Antigen Receptor T Cells? CANCERS 2022
What lies behind paraneoplastic hypercalcemia secondary to well-differentiated neuroendocrine neoplasms. A systematicv review of the literature JOURNAL OF PERSONALIZED MEDICINE 2022
Neuroendocrine neoplasms in the context of inherited tumor syndromes: a reappraisal focused on targeted therapies JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION 2022
Health-related quality of life in patients with neuroendocrine neoplasms: a two-wave longitudinal study JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION 2022
Sperm culture and bacterial susceptibility to antibiotics in a large andrological population: prevalence and impact on seminal parameters INTERNATIONAL MICROBIOLOGY 2022
Angioside: the role of angiogenesis and hypoxia in lung neuroendocrine tumours according to primary tumour location in left or right parenchyma JOURNAL OF CLINICAL MEDICINE 2022
The role of thyroid function in female and male infertility: a narrative review JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION 2022
Nuclear Medicine and Radiological Imaging of Pancreatic Neuroendocrine Neoplasms: A Multidisciplinary Update JOURNAL OF CLINICAL MEDICINE 2022
Erectile Dysfunction Severity: The Role of Glycometabolic Compensation and Antihyperglycemic Drugs JOURNAL OF CLINICAL MEDICINE 2022
The Effects of Radioligand Therapy on Quality of Life and Sexual Function in Patients with Neuroendocrine Neoplasms CANCERS 2022
Capecitabine and Temozolomide (CAPTEM) in advanced neuroendocrine neoplasms (NENs): a systematic review and pooled analysis CANCER MANAGEMENT AND RESEARCH 2022
Characterization of circulating immune cells and correlation with Tie2/Angiopoietins level in well differentiated neuroendocrine gastroenteropancreatic tumors: a cross-sectional analysis ENDOCRINE 2022
Corticosteroids in oncology: Use, overuse, indications, contraindications. An Italian Association of Medical Oncology (AIOM)/ Italian Association of Medical Diabetologists (AMD)/ Italian Society of Endocrinology (SIE)/ Italian Society of Pharmacology (SIF) multidisciplinary consensus position paper CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY 2022
Prognostic Effect of Lymph Node Metastases and Mesenteric Deposits in Neuroendocrine Tumors of the Small Bowel THE JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM 2022

ERC

  • LS2_1
  • LS2_14
  • LS4_4
  • LS4_9
  • LS4_12
  • LS7_4
  • LS7_8
  • LS7_10
  • LS7_14

KET

  • Life-science technologies & biotechnologies

Interessi di ricerca

La principale area di ricerca sono è l'endocrinologia oncologica con numerose pubblicazioni e progetti clinici e traslazionali sulle neoplasie neuroendocrine, le neoplasie tiroidee, l'iperparatiroidismo, i tumori ipofisari, i feocromocitomi e paragangliomi, le sindromi neoplastiche genetiche multiendocrine. In tale ambito l'interesse di ricerca va dagli studi epidemiologici e di valutazione di fattori prognostici clinici e molecolari, studi sul ruolo della sindrome metabolica, della nutrizione e dei fatoori ambientali sulle neoplasie endocrine e neuroendocrine, studi genetici (ricerca nuove mutazioni, VUS, screening genetico, analisi NGS), studi diagnostici sulla diagnosi biochimica e ormonale e la diagnosi di imaging, studi terapeutici sull'efficacia e tossicità di farmaci biologici come analoghi della somatostatina, dopamino-agonisti, inibitori di mTOR, inibitori tirosino-chinasici. Più di recente interesse per l'andrologia, i tumori testicolari e le malattie genetiche della sfera andrologica

Keywords

neuroendocrine tumors (NETs)
Neuroendocrine neoplasms
multiple endocrine neoplasia type 1
Multiple Endocrine Neoplasia Type 2a/drug therapy
medullary thyroid cancer
Hyperparathyroidism
endocrine disrupting chemicals
Endocrine Gland Neoplasms
Endocrine function
andrological health
Pheochromocytoma

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma